Browse by ["viewname_eprint_cor_ur" not defined]
 | Up a level |
B
Bogdahn, U. and Hau, P. and Brawanski, A. and Schlaier, J. and Mehdorn, M. and Wurm, G. and Pichler, J. and Kunst, M. and Stauder, G. and Schlingensiepen, K. H. (2004) Specific therapy for high-grade glioma by convection-enhanced delivery of the TGF-beta 2 specific antisense oligonucleotide AP 12009. In: 40th Annual Meeting of the American Society of Clinical Oncology, June 05-08, 2004, New Orleans, LA.
Bogdahn, U. and Hau, P. and Olyushin, V. and Mahapatra, A. K. and Parfenov, V. and Venkataramana, N. K. and Wassmann, H. and Ludwig, S. and Heinrichs, H. and Schlingensiepen, K. H. (2008) Targeted therapy with AP 12009 in recurrent or refractory glioblastoma patients: Results of a phase lib study. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 2018. ISSN 0732-183X
Bogdahn, U. and Mahapatra, A. and Olyushin, V. E. and Mouli, C. and Parfenov, V. E. and Stockhammer, G. and Ludwig, S. and Wuerth, G. and Heinrichs, H. and Schlingensiepen, K. (2007) A phase IIb actively controlled study with the TGF-beta-2 inhibitor AP 12009 for recurrent or refractory anaplastic astrocytoma. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2025. ISSN 0732-183X, 1527-7755
Bogdahn, U. and Mahapatra, A. K. and Olyushin, V. and Parfenov, V. and Stockhammer, G. and Ludwig, S. and Wuerth, G. and Heinrichs, H. and Schlingensiepen, K. H. (2008) Results of a phase lib active-controlled study with AP 12009 for patients with recurrent or refractory anaplastic astrocytoma. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 2076. ISSN 0732-183X
Bogdahn, U. and Oliushine, V. E. and Parfenov, V. E. and Kunst, M. and Mahapatra, A. and Sastry, K. V. and Venkataramana, K. N. and Jachimczak, P. and Hau, P. and Schlingensiepen, K. (2006) Results of G004, a phase IIb study in recurrent glioblastoma patients with the TGF-b2 targeted compound AP 12009. JOURNAL OF CLINICAL ONCOLOGY, 24 (18Supp). 71S. ISSN 0732-183X
Bogdahn, U. and Stockhammer, G. and Mahapatra, A. K. and Venkataramana, N. K. and Oliushine, V. E. and Partenov, V. E. and Poverennova, I. E. and Jachimczak, P. and Heinrichs, H. and Schlingensiepen, K. (2010) Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients. JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755
Buchholz, S. and Weber, F. and Schally, A. and Ortmann, O. and Seitz, S. (2010) Combination of antagonists of growth hormone-releasing hormone antagonist (GHRH) with rapamycin as a potential therapy in human breast cancers. JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755
Buchholz, Stefan and Engel, Joerg and Schally, Andrew V. and Seitz, Stephan and Ortmann, Olaf and Emons, Guenter and Mahtani, Reshma L. and Gluck, Stefan and Vogel, Charles L. and Montero, Alberto J. (2013) A randomized, phase II trial of AEZS-108 in chemotherapy refractory triple-negative (ER/PR/HER2-negative) LHRH-R positive metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): TPS11124. ISSN 0732-183X, 1527-7755
C
Corbacioglu, Selim and Steinbach, Daniel and Lode, Holger N. and Gruhn, Bernd and Fruehwald, Michael and Broeckelmann, Mechthild and Suttorp, Meinolf and Escherich, Gabriele and Carlo, Gunnar and Ehlert, Karoline and Meister, Bernhard and Simon, Thorsten and Debatin, Klaus-Michael and Kuhlen, Michaela and Feddersen, Ise (2013) The RIST design: A molecularly targeted multimodal approach for the treatment of patients with relapsed and refractory neuroblastoma. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): 10017. ISSN 0732-183X, 1527-7755
G
Glockzin, G. and Schlitt, H. J. and Piso, P. (2011) Bidirectional intraperitoneal chemotherapy with oxaliplatin in the context of CRS and HIPEC in patients with peritoneal carcinomatosis. JOURNAL OF CLINICAL ONCOLOGY, 29 (4suppl): 568. ISSN 0732-183X, 1527-7755
Glockzin, Gabriel and Gerken, Michael and Lang, Sven A. and Schlitt, Hans J. and Piso, Pompiliu (2014) Comparison of two bidirectional hyperthermic intraperitoneal chemotherapy (HIPEC) regimens in patients with colorectal peritoneal metastasis. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.
H
Hau, P. and Bogdahn, U. and Olyushin, V. E. and Mahapatra, A. and Parfenov, V. E. and Venkataramana, K. and Ludwig, S. and Jachimczak, P. and Heinrichs, H. and Schlingensiepen, K. (2007) Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 12521. ISSN 0732-183X, 1527-7755
Hau, P. and Jauch, T. and Hirschmann, B. and Drechsel, E. and Grauer, O. and Koch, H. and Wismeth, C. and Steinbrecher, A. and Bogdahn, U. (2004) Adjuvant chemotherapy with temozolomide and pegylated liposomal doxorubicin in the first-line therapy of patients with glioblastoma - A phase-II trial. In: 40th Annual Meeting of the American Society of Clinical Oncology, June 05-08, 2004, New Orleans, LA.
Hau, P. and Kunst, M. and Pichler, J. and Parfenov, V. E. and Sastry, K. V. R. and Spitznagel, L. and Zaaroor, M. and Bogdahn, U. and Schlingensiepen, K. H. (2005) Targeted downregulation of TGF-beta2 as immunotherapy for high-grade glioma: A phase IIb study. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.
Hau, P. and Stockhammer, G. and Kunst, M. and Mahapatra, A. and Sastry, K. V. and Parfenov, V. E. and Leshinsky, V. G. and Jachimczak, P. and Bogdahn, U. and Schlingensiepen, K. (2006) Results of G004, a phase IIb actively controlled clinical trial with the TGF-b2 targeted compound AP 12009 for recurrent anaplastic astrocytoma. JOURNAL OF CLINICAL ONCOLOGY, 24 (18Supp). 74S. ISSN 0732-183X
Heudobler, Daniel and Elger, Tanja and Mayer, Stephanie and Hart, Christina and Vogelhuber, Martin and Grube, Matthias and Hahn, Joachim and Lueke, Florian and Ditz, Diana and Guenther, Andreas and Gramatzki, Martin and Schmidt, Burkhard and Ferenczy, Peter and Herr, Wolfgang and Rechenmacher, Michael and Reichle, Albrecht (2019) Biomodulatory therapy approach with lenalidomide in combination with pioglitazone, dexamethasone, and metronomic low-dose chemotherapy with treosulfan in patients with relapsed/refractory multiple myeloma > second -line. JOURNAL OF CLINICAL ONCOLOGY, 37 (15supp). p. 8037. ISSN 0732-183X, 1527-7755
Holler, Ernst and Hahn, Joachim and Andreesen, Reinhard and Rogler, Gerhard and Brenmoehl, Julia and Greinix, Hildegard and Dickinson, Anne Marie and Socie, Gerard and Wolff, Daniel and Finke, Juergen (2008) NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters. JOURNAL OF CLINICAL ONCOLOGY, 26 (2). pp. 338-339. ISSN 0732-183X
J
Jauch, T. and Hau, P. and Bogdahn, U. (2007) Re-challenge with temozolomide (TMZ) at recurrence in high-grade gliomas (HGG). JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2034. ISSN 0732-183X, 1527-7755
K
Klinkhammer-Schalke, M. and Ehret, C. and Koller, M. and Steinger, B. and Ernst, B. and Hofstaedter, F. and Lorenz, W. (2008) Diagnosis and therapy of illness-related quality of life in breast cancer patients. Results of a randomized clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 9630. ISSN 0732-183X
Klinkhammer-Schalke, Monika and Koller, Michael and Steinger, Brunhilde and Lindberg, Patricia and Hofstaedter, Ferdinand and Lorenz, Wilfried (2012) Treatment of diseased quality of life in specific dimensions: Effectiveness of quality-of-life diagnosis and treatment in a community-based RCT in women with breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 30 (15supp): e16520. ISSN 0732-183X, 1527-7755
Klinkhammer-Schalke, Monika and Lindberg, Patricia and Steinger, Brunhilde and Koller, Michael and Wyatt, Jeremy and Hofstaedter, Ferdinand and Lorenz, Wilfried (2013) Follow-up study of a randomized clinical trial with quality of life diagnosis and therapy: Long-term quality of life of breast cancer survivors. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): e20517. ISSN 0732-183X, 1527-7755
Klinkhammer-Schalke, Monika and Lorenz, W. and Steinger, B. and Jakob, C. and Ernst, B. and Hofstaedter, Ferdinand and Koller, M. (2005) Enhancing the status of quality-of-life diagnostics in caring for breast cancer patients: Results from a multilevel implementation study in a regional tumor centre. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.
L
Lang, S. A. and Moser, C. and Jung, E. M. and Pfister, K. and Geissler, E. K. and Schlitt, H. J. (2011) Effects of ASA404, a vascular disrupting agent, on tumor growth of gastric cancer in an experimental model. JOURNAL OF CLINICAL ONCOLOGY, 29 (4suppl): 48. ISSN 0732-183X, 1527-7755
Lang, Sven A. and Brandes, Franziska and Geissler, Edward K. (2013) Inhibition of cMET in an experimental model of pancreatic cancer. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.
Lorenz, W. and Klinkhammer-Schalke, M. and Ernst, B. and Jakob, C. and Steinger, B. and Hofstaedter, Ferdinand and Koller, M. (2005) Implementing a clinical pathway for quality-of-life diagnostics and therapy in follow-up of breast cancer patients. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.
M
Mackensen, Andreas and Meidenbauer, Norbert and Vogl, Sandra and Laumer, Monika and Berger, Jana and Andreesen, Reinhard (2006) Phase I study of adoptive T-cell therapy using antigen-specific CD8(+) T cells for the treatment of patients with metastatic melanoma. JOURNAL OF CLINICAL ONCOLOGY, 24 (31). pp. 5060-5069. ISSN 0732-183X
Moser, C. and Ruemle, P. and Schenk, H. and Geissler, E. K. and Schlitt, H. J. and Stoeltzing, O. and Lang, S. A. (2011) Signal transducer and activator of transcription 5b (STAT5b) as a novel target for anti-neoplastic therapy in human pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 29 (4suppl): 217. ISSN 0732-183X, 1527-7755
N
Nemec, Wolfgang and Klinkhammer-Schalke, Monika and Ortmann, Olaf and Buchholz, Stefan (2015) Sarcoma risk after laparoscopic surgery: A retrospective analysis. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.
P
Piso, P. and Glockzin, G. and Schlitt, H. J. (2011) Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis arising from gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 29 (4suppl): 132. ISSN 0732-183X, 1527-7755
R
Reichle, A. and Klebl, F. and Bross, K. and Berand, A. and Wagner, H. and Krause, S. W. and Kullmann, F. and Bataille, F. and Andreesen, R. (2004) Anti-inflammatory therapy combined with angiostatic scheduling of chemotherapy in advanced biliary tract cancer, hepatocellular carcinoma and gastric cancer. In: 40th Annual Meeting of the American Society of Clinical Oncology, June 05-08, 2004, New Orleans, LA.
Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Hubner, J. and Oberneder, R. and Baier, M. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2011) A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 4599. ISSN 0732-183X, 1527-7755
Reichle, A. and Vogt, T. and Coras, B. and Bross, K. and Terhheyden, P. and Neuber, K. and Trefzer, U. and Schultz, E. and L. Fischer von Weikersthal, L. and Andreesen, R. (2005) Metronomic chemotherapy plus/minus antiinflammatory treatment in far-advanced melanoma: A randomized multi-institutional phase II trial. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.
Reichle, A. and Walpinski, S. and Vogelhuber, M. and Wiedmann, K. and Berand, A. and Endlicher, E. and Klebl, F. and Schoelmerich, J. and Andreesen, R. and Wiest, R. (2008) Targeted anti-inflammatory and angiostatic therapy in pretreated patients with advanced hepatocellular carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 15560. ISSN 0732-183X
Reichle, A. and Walter, B. and Berand, A. and Vogelhuber, M. and Bross, K. and Wilke, J. and Wieland, W. and Andreesen, R. and Rogenhofer, S. (2007) Induction of complete remission in metastatic hormone-refractory prostate cancer: A combined anti-inflammatory therapy approach. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 15636. ISSN 0732-183X, 1527-7755
S
Schaefer, Christof and Dietl, Barbara and Loew, Thomas H. and Koelbl, Oliver (2006) What about the family when a terminally ill cancer patient makes a request for euthanasia? JOURNAL OF CLINICAL ONCOLOGY, 24 (19). pp. 3211-3212. ISSN 0732-183X
Schalke, B. (2010) Treatment of unresectable thymoma with neoadjuvant octreotide LAR. JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755
Schalke, Berthold and Boy, Sandra and Hofmann, Hans-Stefan and Stroebel, Philipp and Marienhagen, Joerg and May, Christoph and Stuermer, Andrea and Marx, Alexander (2012) Neoadjuvant treatment of primary inoperable or local recurrent thymoma with octreotide LAR to improve tumor resectability. JOURNAL OF CLINICAL ONCOLOGY, 30 (15supp): 7105. ISSN 0732-183X, 1527-7755
Steinbrecher, A. and Beier, D. and Jauch, T. and Hau, P. and Baumgart, U. and Wismeth, C. and Bogdahn, U. (2005) Adjuvant chemotherapy with temozolomide and liposomal doxorubicin in the first-line therapy of patients with glioblastoma: A phase-II trial. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.
T
Teufel, Andreas and Gerken, Michael and Hartl, Janine and Itzel, Timo and Fichtner-Feigl, Stefan and Stroszczynski, Christian and Schlitt, Hans J. and Hofstaedter, Ferdinand and Klinkhammer-Schalke, Monika (2015) Benefit of adjuvant chemotherapy in patients with T4, UICC II colon cancer. JOURNAL OF CLINICAL ONCOLOGY, 33 (3suppl): 700. ISSN 0732-183X, 1527-7755
W
Weckermann, Dorothea and Polzer, Bernhard and Ragg, Thomas and Blana, Andreas and Schlimok, Guenter and Arnholdt, Hans and Bertz, Simone and Harzmann, Rolf and Klein, Christoph A. (2009) Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer. JOURNAL OF CLINICAL ONCOLOGY, 27 (10). pp. 1549-1556. ISSN 0732-183X, 1527-7755
